APA
Agus D. B., Gordon M. S., Taylor C., Natale R. B., Karlan B., Mendelson D. S., Press M. F., Allison D. E., Sliwkowski M. X., Lieberman G., Kelsey S. M. & Fyfe G. (20050505). Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Agus David B, Gordon Michael S, Taylor Charles, Natale Ronald B, Karlan Beth, Mendelson David S, Press Michael F, Allison David E, Sliwkowski Mark X, Lieberman Gracie, Kelsey Stephen M and Fyfe Gwen. 20050505. Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Agus D. B., Gordon M. S., Taylor C., Natale R. B., Karlan B., Mendelson D. S., Press M. F., Allison D. E., Sliwkowski M. X., Lieberman G., Kelsey S. M. and Fyfe G. (20050505). Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Agus David B, Gordon Michael S, Taylor Charles, Natale Ronald B, Karlan Beth, Mendelson David S, Press Michael F, Allison David E, Sliwkowski Mark X, Lieberman Gracie, Kelsey Stephen M and Fyfe Gwen. Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20050505.